Literature DB >> 25451715

Influence of E. coli-induced prostatic inflammation on expression of androgen-responsive genes and transforming growth factor beta 1 cascade genes in rats.

Yasuhito Funahashi1, Zhou Wang, Katherine J O'Malley, Pradeep Tyagi, Donald B DeFranco, Jeffrey R Gingrich, Ryosuke Takahashi, Tsuyoshi Majima, Momokazu Gotoh, Naoki Yoshimura.   

Abstract

BACKGROUND: Prostatic inflammation is reportedly associated with the development of prostatic hyperplasia. We investigated the effects of prostatic inflammation on expression levels of androgen-responsive genes and growth factors in the rat prostate.
METHODS: Prostatic inflammation was induced by Escherichia coli (strain 1677) injection (0.2 ml of 1 × 10(8) CFU/ml) into the prostatic urethra of male Sprague-Dawley rats, and ventral lobes of the prostate were harvested on day 84. Rats were given 10 mg/kg celecoxib during the last month in the COX-2 inhibitor treated group. Histopathology and multiplex enzyme-linked immunosorbent assay (ELISA) for inflammation-related proteins were performed. Glandular epithelial cells and stromal regions were separately isolated using laser-capture microdissection (LCM). Real-time RT-PCR was performed to examine mRNA levels of androgen-responsive genes in the epithelium and tumor growth factor-β1 (TGF-β1) cascade genes in the stroma.
RESULTS: Hematoxylin and eosin staining showed that mild inflammation was distributed diffusely throughout the prostate. Polymorphonuclear cells infiltrated the slightly edematous stroma, but no morphological changes were observed in the epithelium. Immunohistochemically, expression of androgen receptor and TGF-β1 in addition to IL-6 and cyclooxigenase-2 (COX-2) were enhanced in the E. coli inoculated rats. All of these factors were suppressed in the celecoxib-treated rats. Upregulation of IL-1α, IL-1β, IL-6, and RANTES in the E. coli-inoculated rats was normalized by celecoxib treatment. Significant upregulation of androgen receptor and androgen-responsive genes such as Eaf2, ELL2, FKBP5, calreticulin, and ornithine decarboxylase was observed in the LCM-dissected epithelium. Also TGF-β1 and its downstream cascade genes such as Hic-5, collagen 1, and fibronectin were upregulated significantly in the LCM-dissected stroma. The COX-2 inhibitor treatment suppressed upregulation of these genes.
CONCLUSIONS: Prostatic inflammation changed the expression of androgen-responsive genes in the epithelium and TGF-β1 cascade genes in the stroma. Activation of TGF-β1 cascade genes in the inflamed stroma, as well as altered androgen-responsive gene expression in the epithelium, might be involved in the development of BPH. Prostate 75:381-389, 2015.
© 2014 Wiley Periodicals, Inc. © 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  TGF-β1; androgen receptor; inflammation; laser capture microdissection; prostate

Mesh:

Substances:

Year:  2014        PMID: 25451715      PMCID: PMC4293351          DOI: 10.1002/pros.22924

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  40 in total

1.  RNA interference-mediated cyclooxygenase-2 inhibition prevents prostate cancer cell growth and induces differentiation: modulation of neuronal protein synaptophysin, cyclin D1, and androgen receptor.

Authors:  Bhagavathi A Narayanan; Narayanan K Narayanan; Leland Davis; Dominick Nargi
Journal:  Mol Cancer Ther       Date:  2006-05       Impact factor: 6.261

2.  The etiology of benign prostatic hypertrophy.

Authors:  W G Roper
Journal:  Med Hypotheses       Date:  1998-01       Impact factor: 1.538

3.  Androgen receptor transactivity is potentiated by TGF-β1 through Smad3 but checked by its coactivator Hic-5/ARA55 in balding dermal papilla cells.

Authors:  Shigeki Inui; Satoshi Itami
Journal:  J Dermatol Sci       Date:  2011-09-01       Impact factor: 4.563

4.  Increased expression of lymphocyte-derived cytokines in benign hyperplastic prostate tissue, identification of the producing cell types, and effect of differentially expressed cytokines on stromal cell proliferation.

Authors:  Gero Kramer; Georg E Steiner; Alessandra Handisurya; Ursula Stix; Andrea Haitel; Birgit Knerer; Alois Gessl; Chung Lee; Michael Marberger
Journal:  Prostate       Date:  2002-06-01       Impact factor: 4.104

5.  Acute inflammation promotes early cellular stimulation of the epithelial and stromal compartments of the rat prostate.

Authors:  Amado A Quintar; Andreas Doll; Carolina Leimgruber; Claudia M Palmeri; Felix D Roth; Mariana Maccioni; Cristina A Maldonado
Journal:  Prostate       Date:  2010-08       Impact factor: 4.104

6.  Combination therapy with rofecoxib and finasteride in the treatment of men with lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH).

Authors:  Franco Di Silverio; Cesare Bosman; Monti Salvatori; Luca Albanesi; Laura Proietti Pannunzi; Mauro Ciccariello; Antonio Cardi; Gianfilippo Salvatori; Alessandro Sciarra
Journal:  Eur Urol       Date:  2005-01       Impact factor: 20.096

7.  Longitudinal association between prostatitis and development of benign prostatic hyperplasia.

Authors:  Jennifer L St Sauver; Debra J Jacobson; Michaela E McGree; Cynthia J Girman; Michael M Lieber; Steven J Jacobsen
Journal:  Urology       Date:  2008-03       Impact factor: 2.649

8.  Expression and function of pro-inflammatory interleukin IL-17 and IL-17 receptor in normal, benign hyperplastic, and malignant prostate.

Authors:  Georg E Steiner; Martin E Newman; Doris Paikl; Ursula Stix; Nima Memaran-Dagda; Chung Lee; Michael J Marberger
Journal:  Prostate       Date:  2003-08-01       Impact factor: 4.104

9.  Chronic inflammation in benign prostate hyperplasia is associated with focal upregulation of cyclooxygenase-2, Bcl-2, and cell proliferation in the glandular epithelium.

Authors:  Wanzhong Wang; Anders Bergh; Jan-Erik Damber
Journal:  Prostate       Date:  2004-09-15       Impact factor: 4.104

10.  Prevalence of inflammation and benign prostatic hyperplasia on autopsy in Asian and Caucasian men.

Authors:  Alexandre R Zlotta; Shin Egawa; Dmitry Pushkar; Alexander Govorov; Takahiro Kimura; Masahito Kido; Hiroyuki Takahashi; Cynthia Kuk; Marta Kovylina; Najla Aldaoud; Neil Fleshner; Antonio Finelli; Laurence Klotz; Gina Lockwood; Jenna Sykes; Theodorus van der Kwast
Journal:  Eur Urol       Date:  2014-07-08       Impact factor: 20.096

View more
  14 in total

1.  E-cadherin expression is inversely correlated with aging and inflammation in the prostate.

Authors:  Laura E Pascal; Rajiv Dhir; Goundappa K Balasubramani; Wei Chen; Chandler N Hudson; Pooja Srivastava; Anthony Green; Donald B DeFranco; Naoki Yoshimura; Zhou Wang
Journal:  Am J Clin Exp Urol       Date:  2021-02-15

2.  Urethral dysfunction in a rat model of chemically induced prostatic inflammation: potential involvement of the MRP5 pump.

Authors:  Eduardo C Alexandre; Nailong Cao; Shinsuke Mizoguchi; Tetsuichi Saito; Masahiro Kurobe; Daisuke Gotoh; Meri Okorie; Taro Igarashi; Edson Antunes; Naoki Yoshimura
Journal:  Am J Physiol Renal Physiol       Date:  2020-02-10

3.  Conditional deletion of ELL2 induces murine prostate intraepithelial neoplasia.

Authors:  Laura E Pascal; Khalid Z Masoodi; June Liu; Xiaonan Qiu; Qiong Song; Yujuan Wang; Yachen Zang; Tiejun Yang; Yao Wang; Lora H Rigatti; Uma Chandran; Leandro M Colli; Ricardo Z N Vencio; Yi Lu; Jian Zhang; Zhou Wang
Journal:  J Endocrinol       Date:  2017-11       Impact factor: 4.286

4.  Grape Powder Supplementation Attenuates Prostate Neoplasia Associated with Pten Haploinsufficiency in Mice Fed High-Fat Diet.

Authors:  Tanvi Joshi; Ishani Patel; Avinash Kumar; Virginia Donovan; Anait S Levenson
Journal:  Mol Nutr Food Res       Date:  2020-07-12       Impact factor: 5.914

5.  Cross-organ sensitization between the prostate and bladder in an experimental rat model of lipopolysaccharide (LPS)-induced chronic pelvic pain syndrome.

Authors:  Ozgu Aydogdu; Pinar Uyar Gocun; Patrik Aronsson; Thomas Carlsson; Michael Winder
Journal:  BMC Urol       Date:  2021-08-21       Impact factor: 2.264

Review 6.  Inflammatory mediators in the development and progression of benign prostatic hyperplasia.

Authors:  Cosimo De Nunzio; Fabrizio Presicce; Andrea Tubaro
Journal:  Nat Rev Urol       Date:  2016-09-30       Impact factor: 14.432

7.  Transforming growth factor beta 1 impairs benign prostatic luminal epithelial cell monolayer barrier function.

Authors:  Feng Li; Laura E Pascal; Ke Wang; Yibin Zhou; Goundappa K Balasubramani; Katherine J O'Malley; Rajiv Dhir; Kai He; Donna Stolz; Donald B DeFranco; Naoki Yoshimura; Joel B Nelson; Tie Chong; Peng Guo; Dalin He; Zhou Wang
Journal:  Am J Clin Exp Urol       Date:  2020-02-25

8.  A Role of the Heme Degradation Pathway in Shaping Prostate Inflammatory Responses and Lipid Metabolism.

Authors:  Lisa Vikström Lilljebjörn; Eva Csizmadia; Andreas Hedblom; Giacomo Canesin; Alireza Kalbasi; Mailin Li; Farah Kramer; Karin E Bornfeldt; Barbara Wegiel
Journal:  Am J Pathol       Date:  2020-02-05       Impact factor: 4.307

9.  Associations of TGFBR1 and TGFBR2 gene polymorphisms with the risk of hypospadias: a case-control study in a Chinese population.

Authors:  Xin-Rui Han; Xin Wen; Shan Wang; Xiao-Wu Hong; Shao-Hua Fan; Juan Zhuang; Yong-Jian Wang; Zi-Feng Zhang; Meng-Qiu Li; Bin Hu; Qun Shan; Chun-Hui Sun; Ya-Xing Bao; Meng Lin; Tan He; Dong-Mei Wu; Jun Lu; Yuan-Lin Zheng
Journal:  Biosci Rep       Date:  2017-10-06       Impact factor: 3.976

10.  Hydrogen peroxide inducible clone-5 sustains NADPH oxidase-dependent reactive oxygen species-c-jun N-terminal kinase signaling in hepatocellular carcinoma.

Authors:  Jia-Ru Wu; Ren-In You; Chi-Tan Hu; Chuan-Chu Cheng; Rudy Rudy; Wen-Sheng Wu
Journal:  Oncogenesis       Date:  2019-08-06       Impact factor: 7.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.